Visualitza per autor "Barba, Pere"
Ara mostrant els elements 1-9 d 9
-
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality
Hansen, Doris; Bachy, Emmanuel; bansal, radhika; Rejeski, Kai; Wang, Yucai; IACOBONI, GLORIA; Barba, Pere (American Society of Hematology, 2024-04-23) -
Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL
Busch, Galina; Baumann, Stephan; Jitschin, Regina; Iraola, Josu; Blumenberg , Viktoria; IACOBONI, GLORIA; Gallur, Laura; Barba, Pere (The American Society of Hematology, 2023-11-28) -
Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy
Socie, Gerard; Barlev, Arie; Sanz, Jaime; Garcia Cadenas, Irene; chevallier, patrice; Barba, Pere (Springer Nature, 2024-01) -
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study
Solano, Carlos; Castro Rebollo, Pedro; Pérez Martínez, Antonio; Kwon, Mi; Lopez Corral, Lucia; Barba, Pere (BMJ, 2023-07-25) -
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
IACOBONI, GLORIA; Rejeski, Kai; Villacampa Javierre, Guillermo; van Doesum, Jaap; CHIAPPELLA, ANNALISA; Bonifazi, Francesca; Camacho-Arteaga, Lina ; Marin Niebla, Ana; Barba, Pere (American Society of Hematology, 2022-06-28) -
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
Burchert, Andreas; SESQUES, Pierre; Fransecky, Lars; Rejeski, Kai; IACOBONI, GLORIA; Barba, Pere; Bücklein, Veit (American Society of Hematology, 2022-08-23) -
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
Perez, Ariel; Blumenberg , Viktoria; Bücklein, Veit; Völkl, Simon; Rejeski, Kai; IACOBONI, GLORIA; Barba, Pere (American Association for the Advancement of Science, 2023-09-22) -
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL
Wang, Yucai; albanyan, omar; Munoz, Javier; Rejeski, Kai; SESQUES, Pierre; IACOBONI, GLORIA; Barba, Pere (Wiley, 2023-11) -
Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies
León-Román, Juan; Bolufer Cardona, Monica; Sánchez-Salinas, Mario; Alonso-Martínez, Carla; Bestard, Oriol; IACOBONI, GLORIA; Bermejo García, Sheila; Cecilia del Carmen, Carpio Segura; Garcia-Carro, Clara; Barba, Pere; Soler, María José (Oxford University Press, 2024-03)